MediSix Therapeutics
Manufacturing · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11 Biopolis Way Helios 05-08/09, Singapo...Phone Number
(617) 686-3640Website
www.medisixtx.comRevenue
<$5 MillionIndustry
About MediSix Therapeutics
MediSix Therapeutics specializes in developing innovative T-cell therapies aimed at transforming the treatment of cancer and autoimmune diseases. Founded by Professor Dario Campana in 2016, the company leverages proprietary technologies, including their unique PEBL solution, to enhance T-cell function and address challenges in CAR T-cell therapy. Their robust research pipeline focuses on complex and rare T-cell malignancies, targeting patients in need of advanced therapeutic options. The company is headquartered in Singapore and is led by a team of experienced professionals in the biomedical and pharmaceutical industries.Explore more
MediSix Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to MediSix Therapeutics
Compare insights from companies similar to MediSix Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MediSix Therapeutics Tech Stack
A closer look at the technologies used by MediSix Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MediSix Therapeutics
Sign Up For FreeTo access detailed company insights
MediSix Therapeutics specializes in developing innovative T-cell therapies aimed at transforming the treatment of cancer and autoimmune diseases. Founded by Professor Dario Campana in 2016, the company leverages proprietary technologies, including their unique PEBL solution, to enhance T-cell function and address challenges in CAR T-cell therapy. T... Read More
